Xinhua News Agency reporter
At present, the mutated new coronavirus Omicron strain is spreading rapidly around the world, and the epidemic situation in many countries is severe. It is the top priority to ensure sufficient vaccine supply and fair distribution. Regrettably, despite the current increase in global vaccine production and vaccination rates, the “immunization gap” between developed and developing countries is widening.
Since 2021, China has started the second half of its anti-epidemic cooperation focusing on vaccine cooperation. As of December 26, 2021, China has provided more than 2 billion doses of COVID-19 vaccines to more than 120 countries and international organizations, becoming the country that provides the most vaccines. China‘s vaccines span mountains and seas, and contribute to maintaining global public health security and building a human immune barrier.
Do your best to provide vaccines
One out of every two doses of COVID-19 vaccines used globally is “Made in China“. Most of the vaccines that many countries, especially developing countries, have obtained so far have come from China. At the end of November 2021, at the opening ceremony of the 8th Ministerial Conference of the Forum on China-Africa Cooperation held in Dakar, the capital of Senegal, China announced that it will provide another 1 billion doses of vaccines to Africa, of which 600 million doses are free aid and 400 million doses. Provided in the form of joint production between Chinese companies and relevant African countries, to help African countries achieve the goal of 60% of the African population vaccinated by 2022 set by the African Union.
Mozambique was one of the first African countries to receive a new round of vaccine donations after the Dakar meeting. A new batch of Sinopharm’s new crown vaccine arrived in the country in December last year. At the time of the vaccine handover ceremony, Mozambique’s Minister of Health Thiago said that Mozambique was facing a new round of epidemic pressure, with new daily new crown infections, hospitalizations and deaths showing a rising trend. Help Mo to speed up vaccination.
A new batch of vaccines aided by China will also arrive in Zimbabwe one after another. Zimbabwean President Mnangagwa said in a televised speech on the 12th that the vaccine assistance to Zimbabwe reflects that the Chinese dialect must practice. Thanks to China‘s strong support, many African countries, including Zimbabwe, and other developing countries have obtained effective and affordable vaccines.
Chinese vaccines are also the main source of vaccine use in many Latin American countries. El Salvador’s Health Minister Francisco Arabi said in an interview with Xinhua News Agency a few days ago that in the context of the global shortage of new crown vaccines, El Salvador originally expected to face vaccine-related problems until 2022. China has helped El Salvador to solve the problem of vaccine supply with practical actions.
Protection effectiveness is constantly verified
As the scale of vaccination continues to expand globally, the safety and efficacy of Chinese vaccines have been fully verified. Dimas Covas, director of Brazil’s Butantan Institute, said at a press conference on the 12th: “From the perspective of Brazil and Chile, the Sinovac vaccine is responding to mutant strains such as Delta and Omicron. It shows strong protective efficacy.” Kovas said that the biggest advantage of Sinovac vaccine is that the side effects are extremely low, and at the same time, it can produce more comprehensive protection against the virus.
Benigna Mazzine, deputy director of the National Public Health Agency of Mozambique’s Ministry of Health, said: “The Chinese vaccine is safe… It also has the advantage of less demanding storage conditions. As an underdeveloped country, we The cold chain transportation conditions in China are very limited, and the Chinese vaccine can make our nationwide vaccination more smooth and efficient.”
Nicholas Moussa Mmadi, director of the National Central Hospital of Romaruf in Comor, said recently that the hospital alone has completed two doses of the Chinese national medicine vaccine for about 10,000 people. When the latest wave of outbreaks hit the hospital, there were no cases of vaccinated patients who died from the new coronavirus. “We are very pleased with the overall effect of the vaccine.”
Estelle Sabino, an immunologist at the University of Sao Paulo who was responsible for the genetic sequencing of the new coronavirus in Brazil, believes that the Sinovac vaccine has few side effects and is well-documented in terms of safety and efficacy. She suggested that Brazil should vaccinate children with the Sinovac vaccine as soon as possible in response to the spread of the Omicron mutant strain.
On September 16, 2021, staff are busy at the vaccination point of the Golden Plaza shopping center in Bogota, Colombia. (Published by Xinhua News Agency)
“Made in China” is deeply rooted in the hearts of the people
Eloisa Bonfa, clinical director of the Clinical Hospital of the University of Sao Paulo, Brazil, said that Sinovac vaccine started the vaccination process in Brazil, “This is the first vaccine vaccinated for high-risk groups in Brazil, Sinovac vaccine protects the elderly at the first time. people, frontline healthcare workers and immunocompromised populations.”
In an interview with Xinhua News Agency, Barbosa, director of the Department of Health of Colombia’s Amazon Province, said: “People are now asking for the Kexing vaccine when they come to get the booster shots, because there are no obvious adverse reactions after the Kexing vaccine, and most people in our province have I have great confidence in this vaccine.”
Mmadi said: “We are confident to overcome the epidemic. Compared with the initial stage of the epidemic, we are now better prepared, with better equipment and more trained medical staff.” Various forms of support, including assisting multiple batches of anti-epidemic materials and new crown vaccines, dispatching short-term anti-epidemic medical teams, and building new crown patient isolation points, etc. (Note-taking writer: Luo Guofang; participating reporters: Zhang Yuliang, Nie Zuozu, Bai Lin, Chen Haoqi, Zhu Yubo, Wu Hao, Gao Chunyu, Yin Nan, Zhang Xiaoran, Ni Ruijie, Zhang Dongqiang, Ling Xin, Dong Jianghui, Chen Hao)